Table 4. Levels of biomarkers of the LL DEEP cohort: general population.

Plasma biomarkers (median [Q1; Q3])	n = 958
Citrulline (μmol/l)	41.2 [34.7; 49.1]
IL-1β (μg/l)	0.11 [0.10; 1.00]
IL-6 (μg/l)	0.19 [0.18; 0.20]
IL-8 (μg/l)	1.91 [1.30; 2.77]
IL-10 (μg/l)	0.89 [0.56; 1.23]
IL-12p70 (μg/l)	1.14 [0.06; 2.25]
TNF-α (μg/l)	0.08 [0.07; 0.09]
Fecal biomarkers (median [Q1; Q3])
Chromogranin A (CgA) (nmol/g)	11.1 [7.2; 23.4]
Calprotectin (μg/g)	31.6 [10.5; 60.4]
Human β-defensin 2 (HBD2) (ng/g)	36.8 [22.5; 62.2]
SCFA (C2): Acetate (μmol/g)	27.8 [19.6; 47.1]
SCFA (C3): Propionate (μmol/g)	7.8 [5.2; 11.6]
SCFA (C4): Butyrate (μmol/g)	7.9 [5.0; 12.5]
SCFA (C5): Valerate (μmol/g)	1.4 [1.0; 2.0]
SCFA (C6): Caproate (μmol/g)	0.3 [0.1; 0.8]